CEO Warbington Buys 1M Shares Amid CMT’s Bold BioDefense Takeover: Confidence or Risk?
CEO Warbington’s 1 M share buy in Creative Medical Technology signals confidence in its BioDefense acquisition, but stock remains highly volatile.
2 minutes to read